Latest in AIMS Psilocybin Right-To-Try Effort

Latest in AIMS Psilocybin Right-To-Try EffortWe have taken an additional step recently in our effort to secure psilocybin therapeutic use for two of our cancer patients under State and Federal Right to Try (RTT) laws. On Monday 3/8/21, on behalf of AIMS Institute and Dr. Aggarwal, lawyers filed a petition for review in U.S. Ninth Circuit Court of Appeals of the DEA’s written decision last month to deny our request for RTT access to psilocybin from a duly licensed producer.

Below is the press release that went out and links to some news stories that have appeared.

We are looking for leading organizations committed to protecting the rights of seriously ill patients to have immediate access to safe use of psychedelic-assisted therapy to file ‘friend of the court’ amicus briefs in the case. Please get in touch if your organization or one you know of is interested in lending their voice of support to help our patients receive therapeutic access to the eligible investigational drug psilocybin under right to try. We have a great opportunity here to help advance this very needed therapeutic modality in contemporary hospice and palliative care. Patients treated by palliative care and mental health specialists in Canada have already been able to avail fungal psilocybin-assisted therapy legally under Canadian government exemptions for the past 7 months, and it has been very beneficial in palliation of existential and other distress by all reports.

Press Release: NATION’S FIRST LEGAL CHALLENGE TO ALLOW PSILOCYBIN THERAPY IN END-OF-LIFE CARE UNDER “RIGHT-TO-TRY” LAWS MOVES FORWARD
https://goteamtbg.com/dying-patients-need-access-to-psilocybin-for-anxiety-and-depression-relief/

Oregon Public Broadcasting: Physicians ask DEA to rethink ban on psilocybin
https://www.opb.org/article/2021/03/09/physicians-ask-dea-to-rethink-ban-on-psilocybin/

Marijuana Moment: DEA Sued By Doctor Who Wants Permission To Give Psilocybin Mushrooms To Patients
https://www.marijuanamoment.net/dea-sued-by-therapists-who-want-permission-to-give-psilocybin-mushrooms-to-patients/

Clinician, Patients Take the Fight for Psilocybin To Court
https://www.psychiatrictimes.com/view/clinician-patients-take-fight-psilocybin-to-court

Why Dying Patients Are Suing for Access to Magic Mushrooms
https://today.westlaw.com/Document/Icf70e0e081e411eb835ee9025e2233da/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0

Seattle Doctor, Lawyer Speak Out on Landmark DEA Psilocybin Lawsuit
truffle.report/seattle-doctor-lawyer-speak-out-on-landmark-dea-psilocybin-lawsuit/

Seattle Doctor, Lawyer Speak Out on Landmark DEA Psilocybin Lawsuit
truffle.report/seattle-doctor-lawyer-speak-out-on-landmark-dea-psilocybin-lawsuit/

Suing the DEA for Access to Psilocybin
https://www.mushroomrevival.com/blogs/podcast/suing-the-dea-for-access-to-psilocybin?fbclid=IwAR1QLWYCMjISeWOdoHQVqlb1PaI1iA8NvsSgh7rut71VqZDQpAjU089fUBstruffle.report/seattle-doctor-lawyer-speak-out-on-landmark-dea-psilocybin-lawsuit/

 

Latest Blog Posts

6 Lessons From My Patients, Who Prepared Me for Cancer

6 Lessons From My Patients, Who Prepared Me for Cancer

Mar . 10 . 2026 Kidney Cancer Association This is a guest post by Alena Guggenheim, N.D., Assistant Professor of Anesthesiology and Perioperative Medicine at the Oregon Health & Science University’s School of Medicine in Portland, Oregon. Dr. Guggenheim was diagnosed with a malignant sarcoma in late 2024 after discovering a large mass on her kidney. I had been feeling slightly off for a week, a subtle wobble in my vision, a quickening of my heart I couldn’t quite name. Then, one night at 3 a.m., I woke dripping in sweat, with the worst headache of my life. I tried to ...

Read More
Welcoming Dr. Rachel Caplan-Erickson, ND, LAc to AIMS Institute

Welcoming Dr. Rachel Caplan-Erickson, ND, LAc to AIMS Institute

Integrative Primary Care | Root-Cause Medicine | Whole-Person Healing We are honored and delighted to welcome Dr. Rachel Caplan-Erickson, ND, LAc to the AIMS Institute team. With over 14 years of clinical experience, Dr. Rachel brings a deeply integrative, root-cause approach to primary care that bridges modern diagnostics with time-honored healing traditions. Her work embodies what AIMS Institute stands for: comprehensive, compassionate, whole-person medicine. A Truly Integrative Approach to Primary Care Dr. Rachel is a licensed naturopathic physician and acupuncturist who provides comprehensive primary care through a uniquely integrative lens. She combines advanced laboratory testing and modern medical diagnostics with ...

Read More
Ketamine assisted psychotherapy in postpartum mood and anxiety disorders: a limited case series

Ketamine assisted psychotherapy in postpartum mood and anxiety disorders: a limited case series

Alka Christnacht1Therry Rose Eparwa1,2Emily Whinkin2*Sunil Aggarwal2,3 The postpartum period is notorious for rapid and profound changes for birthing individuals and their families. Significant shifts to hormonal and physical health, routines and family roles, and the salience of personal and community risk factors all contribute to potential psychiatric and psychological distress for parents, sometimes diagnosed as a postpartum mood or anxiety disorder (PMAD). Existing pharmacologic treatment modalities for PMADs do not comprehensively address the profound shifts of the postpartum period, often inadequate at reaching peak therapeutic efficacy in a shorter time frame, in patient accessibility, or offering sustained benefit. Ketamine assisted ...

Read More

Accessibility Tools

Increase TextIncrease Text
Decrease TextDecrease Text
GrayscaleGrayscale
Invert Colors
Readable FontReadable Font
Reset
Call Us Text Us